Navigation Links
11 Pharmaceutical Titans Headline Chemistry Outsourcing Conference Program in September in New Jersey

LONG BRANCH, N.J., May 15 /PRNewswire/ -- Chemical sourcing executives from the eleven largest pharmaceutical companies will gather to discuss timely issues during the Pharma ChemOutsourcing Conference on September 8-9 in New Jersey. This is the first time that such an impressive gathering of industry management has met to exchange viewpoints on the rapidly globalizing web of materials and services to support R & D activities.

The speakers will represent Abbott Labs, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Pfizer, Schering-Plough, and Wyeth.

The industry sourcing leaders speakers will discuss during panel sessions themselves a wide cadre of topics that will feature speakers from mid-sized and smaller pharmaceutical companies, too. The 95-speaker conference speaker faculty hail from many pharma companies and some suppliers. The conference program may be viewed at

Attendees, exhibitors, and speakers hail from the USA, United Kingdom, India, Germany, Canada, Belgium, Russia, Italy, and a dozen other countries.

1,000 attendees and 100 custom synthesis and other service providers are registered; the current roster is at

Panel discussion topics include:

* Raw material and API sourcing

* Supplier performance metrics

* New regulations in Asia and the cost of sourcing

* Biotech small molecule sourcing needs

* Sourcing synthetic routes & process optimization

* Phase II and commercial sourcing and manufacturing

* Discovery and medicinal chemistry outsourcing models

Overall, 21 such panel discussions are scheduled during the two-day event. Exploding interest in chemical outsourcing activities have shaped the 2008 ChemOutsourcing event into an international meeting place to accommodate the industry need for information and networking, reports Apaporis LLC.

For more information, contact the organizer, Mark Alexay at, 201.452.4023, or visit .

Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
4. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
6. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
8. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
9. Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts Meeting September 28, 2007
10. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Pharmaceutical Manufacturing Quality: Optimizing Your Internal Process for FDA Compliance
Post Your Comments:
(Date:11/30/2015)... ... ... Stress, anxiety, illness, infection or even a need for eyeglasses can sometimes ... MD, a new pediatric neurosurgeon at Joe DiMaggio Children’s Hospital in Hollywood, Florida, said ... , “Bad headaches that don’t go away, that don’t have any other reason, ...
(Date:11/30/2015)... ... November 30, 2015 , ... The Museum ... summer, ushering in a new era of publicly accessible automated technology. Now, by ... continue to offer guests an up-close look at the shuttle at MOSI’s main ...
(Date:11/30/2015)... Angeles, CA (PRWEB) , ... November 30, 2015 , ... ... does matters of personal styling. So why is it a national news story when ... according to Parsa Mohebi, M.D., because appearances count more than anyone wants to admit ...
(Date:11/30/2015)... ... November 30, 2015 , ... The Progressive ... TX, on January 29 and 30, 2016. The course welcomes dental professionals and ... practices, to learn how to better succeed in the modern dental marketplace. The ...
(Date:11/30/2015)... ... November 30, 2015 , ... A novel ... bacteria could be effective in fighting methicillin-resistant Staphylococcus aureus (MRSA), one of the ... study showed that small molecule analogs that target the functions of SecA, a ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... , Nov. 30, 2015 ... the "Orphan Drugs Market 2015-2019" report ... has announced the addition of the "Orphan ... --> Research and Markets ( ... "Orphan Drugs Market 2015-2019" report to their ...
(Date:11/30/2015)... 30, 2015  IBA Molecular North America, Inc. (IBAMNA), ... radiopharmaceuticals, announced that as of January 1, 2016, it ... The decision to rebrand the company reflects a refined ... as its close relationship with Zevacor Molecular.  Both IBAMNA ... Science (IHS). Peter Burke , Vice ...
(Date:11/30/2015)... -- North America was valued at ... a CAGR of 7.6% from 2015 to 2020. --> ... in 2014, and is expected to grow at a CAGR of ... new Market Research Report "North America Cardiac Output Monitoring Devices Market ... care, others) - Analysis And Forecast To 2020", the cardiac output ...
Breaking Medicine Technology: